Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms

Maria Sundvall, Anna Korhonen, Ilkka Paatero, Eugenio Gaudio, Gerry Melino, Carlo M. Croce, Rami I. Aqeilan, Klaus EleniusProceedings of the National Academy of Sciences 2008 · DOI

TL;DR

This study reveals that different versions (isoforms) of the ErbB4 receptor are handled differently by cells, with one type (CYT-1) being efficiently internalized and degraded while another (CYT-2) is not. This difference is driven by a specific sequence motif (PPXY) in the CYT-1 isoform that recruits an E3 ubiquitin ligase called Itch, leading to targeted degradation.

What Problem Does This Paper Address?

The epidermal growth factor receptor (EGFR) family, including ErbB4, plays a crucial role in cell signaling, and their dysregulation is implicated in cancer. While EGFR's signaling is well-understood to be tightly controlled by endocytosis and degradation, other ErbB family members, like ErbB4, have been noted as being less efficiently internalized. ErbB4, in particular, exists in multiple isoforms due to alternative splicing, differing in their juxtamembrane (JM) and cytoplasmic (CYT) domains. The functional consequences of these isoform differences, especially concerning their cellular trafficking and degradation, were not well understood, creating a knowledge gap in how ErbB4 signaling is regulated.

Methods

The researchers employed a combination of standard molecular biology and cell biology techniques:

  • Expression Plasmids and Transfection: They created and used plasmids to express different ErbB4 isoforms (and their mutated versions) in various cell lines (COS-7, HeLa, NIH 3T3, OVCAR-3).
  • Immunofluorescence and Confocal Microscopy: This was used to visualize the subcellular localization of ErbB4 isoforms and their colocalization with endosomal markers (Rab5, Rab7) and the E3 ligase Itch.
  • Internalization Assays: Radioactive ligands (NRG-1, EGF, HB-EGF) were used to quantitatively measure how efficiently ErbB4 isoforms were internalized into cells.
  • Ubiquitination Assays: Cells were treated with ligands and then lysed. ErbB4 was immunoprecipitated, and Western blotting was used with antibodies against ubiquitin (specifically mono- or polyubiquitination) to detect ubiquitination events.
  • Coimmunoprecipitation and GST Pull-Down Assays: These techniques were used to confirm the physical interaction between ErbB4 and the E3 ubiquitin ligase Itch, and to map which domains of Itch were involved.
  • Degradation Assays: Protein synthesis was blocked (using cycloheximide), and the rate of ErbB4 degradation was monitored over time using Western blotting.
  • Mutagenesis: Specific amino acid residues within the ErbB4 sequence were mutated to investigate their role in ubiquitination, endocytosis, and degradation.

Datasets

Not discussed in the paper. The study relies on experimental data generated from cell culture and molecular biology techniques, rather than pre-existing datasets.

Key Insights and Ideas

  • Isoform-Specific Cellular Fate: The most striking finding is that ErbB4's journey within the cell is dictated by its cytoplasmic tail (CYT) isoform. CYT-1 isoforms are efficiently endocytosed and trafficked to late endosomes/lysosomes for degradation, while CYT-2 isoforms are largely resistant to this process.
  • The PPXY Motif as a Key Regulator: A short, 16-amino acid sequence unique to the CYT-1 isoform, containing a PPXY motif, is identified as the critical element responsible for this differential handling.
  • Itch: The Ubiquitin Ligase Partner: This PPXY motif acts as a docking site for the E3 ubiquitin ligase Itch, which belongs to the Nedd4 family. Itch's interaction with the PPXY motif is crucial for ErbB4's ubiquitination and subsequent degradation.
  • Monoubiquitination, Not Polyubiquitination: Itch appears to catalyze monoubiquitination of ErbB4 CYT-1, rather than polyubiquitination, which is a key step in targeting the receptor for lysosomal degradation.
  • Implications for Signaling: The differential degradation rates suggest that ErbB4 CYT-1 and CYT-2 isoforms likely have distinct signaling durations and outputs, contributing to the complexity of ErbB4-mediated cellular responses.

Key Results

  • ErbB4 CYT-1 isoforms were significantly more localized to intracellular vesicles (colocalizing with Rab5 and Rab7) compared to CYT-2 isoforms.
  • Internalization of NRG-1 by ErbB4 CYT-1 was significantly faster and comparable to EGFR, while CYT-2 internalization was impaired.
  • Degradation of ErbB4 CYT-1 was substantially more efficient than CYT-2.
  • Mutating the PPXY motif (specifically P1054A) in CYT-1 abolished its efficient endocytosis and ubiquitination.
  • The E3 ubiquitin ligase Itch physically interacted with ErbB4, with a stronger association observed with CYT-1 than CYT-2.
  • Itch overexpression enhanced ErbB4 CYT-1 ubiquitination, endocytosis, and degradation, while a dominant-negative Itch mutant blocked these processes.
  • Itch primarily catalyzed monoubiquitination of ErbB4 CYT-1.

Limitations and Future Work

  • Cell Line Specificity: While multiple cell lines were used, the findings might not be universally applicable to all cell types expressing ErbB4.
  • In Vivo Relevance: The study primarily uses in vitro cell culture models. Further investigation is needed to confirm these findings in vivo and their physiological significance.
  • Broader Itch-like Ligase Role: The paper suggests that Itch-like E3 ligases are necessary for differential degradation. Future work could explore other Nedd4 family members or related ligases that might also play a role.
  • Signaling Consequences: While the paper infers differential signaling based on degradation rates, a direct analysis of the downstream signaling pathways activated by each isoform would be a valuable next step.
  • Clinical Implications: Understanding how these isoform-specific trafficking mechanisms are altered in disease states (e.g., cancer, neurological disorders mentioned in the introduction) could open avenues for therapeutic intervention.

Summary updated

Abstract

Endocytosis and subsequent lysosomal degradation serve as a well characterized mechanism to fine-tune and down-regulate EGFR signaling. However, other members of the EGFR/ErbB receptor family have been reported to be endocytosis-impaired. Here we demonstrate that endocytosis of ErbB4 is regulated in an isoform-specific manner: CYT-1 isoforms were efficiently endocytosed whereas CYT-2 isoforms were endocytosis-impaired. CYT-1 isoforms in endocytic vesicles colocalized with Rab5 and Rab7 indicating trafficking via early endosomes to late endosomal/lysosomal structures. A PPXY motif within the CYT-1-specific sequence that lacks from CYT-2 was necessary both for ubiquitination and endocytosis of CYT-1 isoforms and provided a binding site for a WW domain-containing ubiquitin ligase Itch. Itch catalyzed ubiquitination of ErbB4 CYT-1, promoted its localization into intracellular vesicles, and stimulated degradation of ErbB4 CYT-1. Dominant negative Itch suppressed ErbB4 CYT-1 endocytosis and degradation. These data indicate that ErbB4 isoforms differ in endocytosis and degradation by a mechanism mediated by CYT-1-specific PPXY motif interacting with a WW domain-containing E3 ubiquitin ligase.
BibTeX
@inproceedings{sundvall2008isoform,
  author = {Maria Sundvall and Anna Korhonen and Ilkka Paatero and Eugenio Gaudio and Gerry Melino and Carlo M. Croce and Rami I. Aqeilan and Klaus Elenius},
  title = {{Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {2008},
  doi = {10.1073/pnas.0708333105},
}
Figure